TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its platform covers treatment for depression, anxiety, post-traumatic stress disorders, bipolar disorders, and obsessive-compulsive disorders. The company's treatment subscription plan includes consultation with a physician, oral ketamine prescription medication, treatment sessions with a licensed medical practitioner, and messaging with a licensed medical practitioner. It serves clients in California, Illinois, Arizona, Colorado, Michigan, Washington, Florida, New York, Ohio, and Virginia. TripSitter Clinic Ltd. is headquartered in Toronto, Canada.

KETA

EURONEXT:KETA

TripSitter Clinic Ltd.

Market Cap

266.33K

Beta: -

PE Ratio

−2.29

PFCF: −0.55

market

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics